Company Overview
Profit after Tax
N/A
Cr
Growth:
N/A
Industry P/S: N/A
Fundamentals
| Sales (Cr) |
₹ N/A |
| Growth |
N/A |
| EBITDA |
N/A |
| P/S |
N/A |
| Dividend |
N/A |
| P/E |
N/A |
| Book Value |
₹ N/A |
| PEG Ratio |
N/A |
| ROE |
N/A |
| P/B |
N/A |
Shareholding Pattern
Increase
Decrease
No change
The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
